Related Experiment Video
Updated: Mar 23, 2026
09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
18.9K
Targeting Protein-Protein Interactions in the HIF System
Sarah E Wilkins1, Martine I Abboud2, Rebecca L Hancock2
1Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK. sarah.wilkins@chem.ox.ac.uk.
Chemmedchem
|March 22, 2016
Summary
Animals adapt to low oxygen levels by activating hypoxia-inducible factor (HIF). Understanding HIF's structure and interactions offers new therapeutic strategies for diseases linked to hypoxia.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The hypoxia-inducible factor (HIF) is crucial for cellular and systemic responses to chronic hypoxia.
- HIF regulates gene expression to counteract the effects of limited oxygen.
- HIF activity is modulated by hydroxylase-catalyzed modifications of HIF-α subunits.
Purpose of the Study:
- To provide an overview of the HIF system.
- To focus on structural insights into HIF protein-protein interactions.
- To explore therapeutic potential by modulating the HIF pathway.
Main Methods:
- Review of structural biology and biochemistry of the HIF system.
- Analysis of protein-protein and protein-nucleic acid interactions within the HIF pathway.
- Examination of HIF hydroxylase-mediated post-translational modifications.
Main Results:
- HIF-α subunit modifications signal for degradation and limit coactivator binding.
- Structural knowledge facilitates medicinal chemistry for therapeutic intervention.
- Multiple targets within the HIF system offer therapeutic possibilities.
Conclusions:
- The HIF system is a key target for treating hypoxia-related diseases.
- Structural biology advances are driving therapeutic development for the HIF pathway.
- Modulating HIF interactions presents significant medicinal potential.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
01:23Hypoxia
2.5K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.5K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:04Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
01:22PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
01:30General Transcription Factors
7.5K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.5K